Geneva, Nov. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134760) titled 'Special Initiative on Integrating AI into Clinical Pharmacy Scenarios to Empower Rational Drug Use in Specialized Departments and Specific Diseases' on Oct. 20.
Study Type: Observational study
Study Design:
Cross-sectional
Primary Sponsor: Putuo District Central Hospital, Shanghai
Condition:
Tumor
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-26
Target Sample Size: the full case dataset:1000;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=348009
Disclaimer: Curated by HT Syndication....